Vir Biotechnology (NASDAQ:VIR) Shares Down 2.7% After Insider Selling

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report)’s share price was down 2.7% on Tuesday after an insider sold shares in the company. The stock traded as low as $11.42 and last traded at $11.58. Approximately 140,465 shares changed hands during trading, a decline of 87% from the average daily volume of 1,121,850 shares. The […]

Related Keywords

Georgea Scangos , ,Jpmorgan Chase Co ,Barclays Plc ,Vanguard Group Inc ,Nasdaq ,Securities Exchange Commission ,Needham Company ,Voloridge Investment Management ,Vir Biotechnology Inc ,Nuveen Asset Management ,Vir Biotechnology ,Get Free Report ,Exchange Commission ,Director George ,Biotechnology Trading Down ,Investment Management ,Asset Management ,Vir Biotechnology Daily ,Nasdaq Vir ,Ivir ,Medical ,Stocks ,Technicals ,